337 related articles for article (PubMed ID: 15082596)
1. Long term prognosis of fatty liver: risk of chronic liver disease and death.
Dam-Larsen S; Franzmann M; Andersen IB; Christoffersen P; Jensen LB; Sørensen TI; Becker U; Bendtsen F
Gut; 2004 May; 53(5):750-5. PubMed ID: 15082596
[TBL] [Abstract][Full Text] [Related]
2. Histological characteristics and prognosis in patients with fatty liver.
Dam-Larsen S; Franzmann MB; Christoffersen P; Larsen K; Becker U; Bendtsen F
Scand J Gastroenterol; 2005 Apr; 40(4):460-7. PubMed ID: 16028442
[TBL] [Abstract][Full Text] [Related]
3. Final results of a long-term, clinical follow-up in fatty liver patients.
Dam-Larsen S; Becker U; Franzmann MB; Larsen K; Christoffersen P; Bendtsen F
Scand J Gastroenterol; 2009; 44(10):1236-43. PubMed ID: 19670076
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease.
Haflidadottir S; Jonasson JG; Norland H; Einarsdottir SO; Kleiner DE; Lund SH; Björnsson ES
BMC Gastroenterol; 2014 Sep; 14():166. PubMed ID: 25260964
[TBL] [Abstract][Full Text] [Related]
5. Presence of alcoholic steatohepatitis, but no selective histological feature, indicates an increased risk of cirrhosis and premature death.
Semb S; Neermark S; Dam-Larsen S; Franzmann MB; Albrectsen J; Kallemose T; Becker U; Bendtsen F
Scand J Gastroenterol; 2016 Nov; 51(11):1367-74. PubMed ID: 27381376
[TBL] [Abstract][Full Text] [Related]
6. Long-term, clinical follow-up in fatty liver patients.
Bendtsen F; Dam-Larsen S
Dig Dis; 2010; 28(6):709-14. PubMed ID: 21525754
[TBL] [Abstract][Full Text] [Related]
7. Low incidence of non-alcoholic steatohepatitis in a Danish liver unit.
Semb S; Dam-Larsen S; Mogensen AM; Albrectsen J; Bendtsen F
Dan Med J; 2012 Jan; 59(1):A4354. PubMed ID: 22239839
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen P; Vilstrup H; Mellemkjaer L; Thulstrup AM; Olsen JH; Baron JA; Sørensen HT
Hepatogastroenterology; 2003; 50(54):2101-4. PubMed ID: 14696473
[TBL] [Abstract][Full Text] [Related]
9. Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study.
Deleuran T; Grønbaek H; Vilstrup H; Jepsen P
Aliment Pharmacol Ther; 2012 Jun; 35(11):1336-42. PubMed ID: 22490057
[TBL] [Abstract][Full Text] [Related]
10. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
Spech HJ; Liehr H; Mitschke H
Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis in alcoholic and nonalcoholic steatohepatitis.
Bataller R; Rombouts K; Altamirano J; Marra F
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):231-44. PubMed ID: 21497741
[TBL] [Abstract][Full Text] [Related]
12. Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease.
Rakha EA; Adamson L; Bell E; Neal K; Ryder SD; Kaye PV; Aithal GP
J Clin Pathol; 2010 Sep; 63(9):790-5. PubMed ID: 20819880
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.
Önnerhag K; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2014 Sep; 49(9):1111-8. PubMed ID: 24990583
[TBL] [Abstract][Full Text] [Related]
14. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
15. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver.
Teli MR; Day CP; Burt AD; Bennett MK; James OF
Lancet; 1995 Oct; 346(8981):987-90. PubMed ID: 7475591
[TBL] [Abstract][Full Text] [Related]
16. [Nonalcoholic and alcoholic steatohepatitis].
Prelipcean CC; Stefănescu C; Mihai C; Drug VL; Constantinescu R
Rev Med Chir Soc Med Nat Iasi; 2003; 107(1):51-8. PubMed ID: 14755970
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.
Dyson JK; McPherson S; Anstee QM
J Clin Pathol; 2013 Dec; 66(12):1033-45. PubMed ID: 23940130
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic steatohepatitis--a long-term follow-up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients.
Cortez-Pinto H; Baptista A; Camilo ME; De Moura MC
Dig Dis Sci; 2003 Oct; 48(10):1909-13. PubMed ID: 14627331
[TBL] [Abstract][Full Text] [Related]
19. Two cases of non-alcoholic steato-hepatitis developing from simple fatty liver.
Kim SR; Nakajima T; Ando K; Mita K; Fukuda K
J Gastrointestin Liver Dis; 2009 Dec; 18(4):491-5. PubMed ID: 20076826
[TBL] [Abstract][Full Text] [Related]
20. Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease.
Siddiqui MS; Patidar KR; Boyett S; Luketic VA; Puri P; Sanyal AJ
Liver Int; 2016 Apr; 36(4):572-9. PubMed ID: 26713759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
